Cullinan Therapeutics (CGEM) Earnings Date & Reports
Cullinan Therapeutics Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CGEM is expected to report earnings to rise 11.74% to -81 cents per share on May 20
Q1'25
Est.
$-0.82
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.13
The last earnings report on March 03 showed earnings per share of -73 cents, beating the estimate of -79 cents. With 600.30K shares outstanding, the current market capitalization sits at 432.99M.